Adolescent obesity and bariatric surgery

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 16, Issue 1, 2009, Pages 37-44

  Levitsky, Lynne L ^a   Misra, Madhusmita ^a   Boepple, Paul A ^a   Hoppin, Alison G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adolescent obesity; Bariatric surgery; Endocrine effects; Outcomes; Weight loss

Indexed keywords

ACUTE DISEASE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY COMPOSITION; BODY FAT DISTRIBUTION; CAUSE OF DEATH; CHRONIC DISEASE; COMORBIDITY; DISEASE SEVERITY; FOOD TRAPPING; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; LAPAROSCOPIC SURGERY; LONG TERM CARE; LUNG EMBOLISM; MORBIDITY; OBESITY; OVERNUTRITION; PERITONITIS; POSTOPERATIVE COMPLICATION; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; ROUX Y ANASTOMOSIS; SUBCUTANEOUS FAT; THROMBOPHLEBITIS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; ADULT; AGE FACTORS; BARIATRIC SURGERY; BODY COMPOSITION; GASTRECTOMY; HUMANS; LAPAROSCOPY; NUTRITION DISORDERS; NUTRITIONAL STATUS; OBESITY, MORBID; PATIENT COMPLIANCE; PUBERTY; PUBERTY, PRECOCIOUS; WEIGHT LOSS;

EID: 58849135829     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e32832101ff     Document Type: Review

References (114)

1. Misra M, Bredella M, Tsai P, Mendes N, Miller KK, Klibanski A. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids and insulin resistance in overweight girls. Am J Physiol Endocrinol Metab 2008; 295:E385-E392.
2. Syme C, Abrahamowicz M, Leonard GT, et al. Intra-abdominal adiposity and individual components of the metabolic syndrome in adolescence: sex differences and underlying mechanisms. Arch Pediatr Adolesc Med 2008; 162:453-461.
3. Reinehr T, Kiess W, de Sousa G, et al. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006; 55:113-118.
4. Schiel R, Beltschikow W, Radon S, et al. Increased carotid intima-media thickness and associations with cardiovascular risk factors in obese and overweight children and adolescents. Eur J Med Res 2007; 12:503-508.
5. Kelishadi R, Hashemi M, Mohammadifard N, et al. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clin Chem 2008; 54:147-153. This study indicates that insulin resistance can be reduced by exercise.
6. Damaso AR, do Prado WL, de Piano A, et al. Relationship between non-alcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis 2008; 40:132-139.
7. Rizzo NS, Ruiz JR, Oja L, et al. Associations between physical activity, body fat, and insulin resistance (homeostasis model assessment) in adolescents: the European Youth Heart Study. Am J Clin Nutr 2008; 87:586-592.
8. Yu Y, Lu BS, Wang B, et al. Short sleep duration and adiposity in Chinese adolescents. Sleep 2007; 30:1688-1697.
9. Must A, Bandini LG, Tybor DJ, et al. Behavioral risk factors in relation to visceral adipose tissue deposition in adolescent females. Int J Pediatr Obes 2008; 3 (Suppl 1):28-36.
10. Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004; 116:337-350.
11. Boyar RM, Katz J, Finkelstein JW, et al. Anorexia nervosa. Immaturity of the 24-h luteinizing hormone secretory pattern. N Engl J Med 1974; 291:861-865.
12. Kulin HE, Bwibo N, Mutie D, Santner SJ. The effect of chronic childhood malnutrition on pubertal growth and development. Am J Clin Nutr 1982; 36:527-536.
13. Frisch RE, Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Science 1970; 169:397-399.
14. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974; 185:949-951.
15. Bluher S, Mantzoros CS. Leptin in reproduction. Curr Opin Endocrinol Diabetes Obes 2007; 14:458-464.
16. Kaplowitz PB. Link between body fat and the timing of puberty. Pediatrics 2008; 121 (Suppl 3):S208-S217.
17. Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 2002; 110:903-910.
18. Rosenfield RL. Clinical review: identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:787-796.
19. Ibanez L, Ong K, Valls C, et al. Metformin treatment to prevent early puberty in girls with precocious pubarche. J Clin Endocrinol Metab 2006; 91:2888-2891.
20. Ibanez L, A L-B, DiazM, MV M, de Zegher F. Metformin treatment for four years to reduce total and visceral fat in low birthweight girls with precocious puberty. J Clin Endocrinol Metab 2008; 93:1841-1845. This study demonstrates that metformin treatment can reduce total and visceral fat and delay the onset of menarche in low birth weight girls.
21. Verhulst S, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents. J Pediatr 2007; 150:608-612. This study highlights central sleep disorders in obese young people.
22. Inge TH, Xanthakos SA, Zeller MH. Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond) 2007; 31:1-14.
23. Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003; 289:1813-1819.
24. Henderson RC, Kemp GJ, Hayes PR. Prevalence of late-onset tibia vara. J Pediatr Orthop 1993; 13:255-258.
25. Sabharwal S, Zhao C, McClemens E. Correlation of body mass index and radiographic deformities in children with Blount disease. J Bone Joint Surg Am 2007; 89:1275-1283.
26. Maggio AB, Aggoun Y, Marchand LM, et al. Associations among obesity, blood pressure, and left ventricular mass. J Pediatr 2008; 152:489-493.
27. Chinali M, de Simone G, Roman MJ, et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 2006; 47:2267-2273.
28. Stabouli S, Kotsis V, Papamichael C, et al. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr 2005; 147:651-656.
29. Mimoun E, Aggoun Y, Pousset M, et al. Association of arterial stiffness and endothelial dysfunction with metabolic syndrome in obese children. J Pediatr 2008; 153:65-70.
30. Freedman DS, Kahn HS, Mei Z, et al. Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 2007; 86:33-40.
31. Quiros-Tejeira T, Rivera C, Ziba T, et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr 2007; 1007:228-236.
32. Imhof A, Kratzer W, Boehm B, et al. Prevalence of nonalcoholic fatty liver and characteristics in overweight adoloescents in the general population. Eur J Epidemiol 2007; 22:889-897.
33. Pacifico L, Cantisani V, Ricci P, et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008; 63:423-427.
34. Must A, Jacques PF, Dallai GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992; 327:1350-1355.
35. Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357:2329-2337.
36. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch Pediatr Adolesc Med 2006; 160:523-528.
37. Liese A, D'Agostino RJ, Hamman R, et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for diabetes in youth strudy group. Pediatrics 2006; 118:1510-1518.
38. Al-Qahtani AR. Laparoscopic adjustable gastric banding in adolescent: safety and efficacy. J Pediatr Surg 2007; 42:894-897.
39. Cunneen SA. Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg Obes Relat Dis 2008; 4:S47-S55.
40. Ettinger LM, Freeman K, DiMartino-Nardi JR, Flynn JT. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005; 147:67-73.
41. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007; 369:1823-1831.
42. Pontiroli AE, Fossati A, Vedani P, et al. Postsurgery adherence to scheduled visits and compliance, more than personality disorders, predict outcome of bariatric restrictive surgery in morbidly obese patients. Obes Surg 2007; 17:1492-1497.
43. Lutfi R, Torquati A, Sekhar N, Richards WO. Predictors of success after laparoscopic gastric bypass: a multivariate analysis of socioeconomic factors. Surg Endosc 2006; 20:864-867.
44. Peluso L, Vanek VW. Efficacy of gastric bypass in the treatment of obesity-related comorbidities. Nutr Clin Pract 2007; 22:22-28.
45. Toouli J, Kow L, Collins J, et al. Efficacy of a low-pressure laparoscopic adjustable gastric band for morbid obesity: patients at long term in a multi-disciplinary center. Surg Obes Relat Dis 2008; 4:S31-S38.
46. Naef M, Naef U, Mouton WG, Wagner HE. Outcome and complications after laparoscopic Swedish adjustable gastric banding: 5-year results of a prospective clinical trial. Obes Surg 2007; 17:195-201.
47. Kim TH, Daud A, Ude AO, et al. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc 2006; 20:202-209.
48. Rosenthal RJ, Szomstein S, Kennedy CI, et al. Laparoscopic surgery for morbid obesity: 1,001 consecutive bariatric operations performed at The Bariatric Institute, Cleveland Clinic Florida. Obes Surg 2006; 16:119-124.
49. Nocca D, Aggarwal R, Blanc P, et al. Laparoscopic vertical banded gastroplasty. A multicenter prospective study of 200 procedures. Surg Endosc 2007; 21:870-874.
50. Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006; 16:1323-1326.
51. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal- jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov 2007; 14:275-278.
52. Goergen M, Arapis K, Limgba A, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty: results of a 2-year follow-up study. Surg Endosc 2007; 21:659-664.
53. Kalfarentzos F, Skroubis G, Kehagias I, et al. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a nonsuper-obese population. Obes Surg 2006; 16:151-158.
54. Gan SS, Talbot ML, Jorgensen JO. Efficacy of surgery in the management of obesity-related type 2 diabetes mellitus. ANZ J Surg 2007; 77:958-962.
55. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg 2007; 17:176-184.
56. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004; 114:217-223.
57. Schilling PL, Davis MM, Albanese CT, et al. National trends in adolescent bariatric surgical procedures and implications for surgical centers of excellence. J Am Coll Surg 2008; 206:1-12. This review demonstrates the increasing frequency of bariatric surgery in adolescents.
58. Sugerman HJ, Sugerman EL, DeMaria EJ, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003; 7:102-107; discussion 7-8.
59. Fleischer J, Stein EM, Bessler M, et al. The Decline in Hip Bone Density Following Gastric Bypass Surgery is Associated with Extent of Weight Loss. J Clin Endocrinol Metab 2008; 93:3735-3740. A cautionary study noting the loss of bone density following bariatric surgery in adults.
60. Ballantyne GH. Peptide YY(1-36) and peptide YY(3-36): part I. distribution, release and actions. Obes Surg 2006; 16:651-658.
61. Coppini LZ, Bertevello PL, Gama-Rodrigues J, Waitzberg DL Changes in insulin sensitivity in morbidly obese patients with or without metabolic syndrome after gastric bypass. Obes Surg 2006; 16:1520-1525.
62. Morinigo R, Casamitjana R, Delgado S, et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007; 30:1906-1908. A demonstration of the rapidity of decrease in insulin resistance following gastric bypass surgery in adults.
63. Perugini RA, Quarfordt SH, Baker S, et al. Metabolic characterization of nondiabetic severely obese patients undergoing Roux-en-Y gastric bypass: preoperative classification predicts the effects of gastric bypass on insulin-glucose homeostasis. J Gastrointest Surg 2007; 11:1083-1090.
64. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab 2007; 92:4678-4685.
65. Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93:2479-2485.
66. Rodieux F, Giusti V, D'Alessio D, et al. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring) 2008; 16:298-305.
67. Fruhbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 2004; 14:606-612.
68. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247:401-407. Demonstraton of metabolic/endocrine mechanisms for appetite decrease and weight loss after bariatric surgery in adults.
69. Chan JL, Mun EC, Stoyneva V, et al. Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring) 2006; 14:194-198.
70. Morinigo R, Vidal J, Lacy AM, et al. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg 2008; 247:270-275.
71. Morinigo R, Moize V, Musri M, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006; 91:1735-1740.
72. Liou JM, Lin JT, Lee WJ, et al. The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery. Obes Surg 2008; 18:84-89.
73. Reinehr T, Roth CL, Schernthaner GH, et al. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg 2007; 17:1571-1577.
74. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243:108-114.
75. Valera Mora ME, Manco M, Capristo E, et al. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery. Obesity (Silver Spring) 2007; 15:2012-2018.
76. Santoro S, Milleo FQ, Malzoni CE, et al. Enterohormonal changes after digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg 2008; 18:17-26.
77. Foschi D, Corsi F, Colombo F, et al. Different effects of vertical banded gastroplasty and Roux-en-Y gastric bypass on meal inhibition of ghrelin secretion in morbidly obese patients. J Invest Surg 2008; 21:77-81.
78. Catalan V, Gomez-Ambrosi J, Ramirez B, et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 2007; 17:1464-1474. Study examines role of inflammatory cytokines in weight loss and insulin resistance after gastric bypass.
79. Molina A, Vendrell J, Gutierrez C, et al. Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Obes Surg 2003; 13:615-621.
80. Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005; 90:316-322.
81. Konukoglu D, Uzun H, Firtina S, et al. Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients. Obes Surg 2007; 17:672-678.
82. Fontana L, Eagon JC, Trujillo ME, et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56:1010-1013.
83. Hanusch-Enserer U, Cauza E, Brabant G, et al. Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. J Clin Endocrinol Metab 2004; 89:3352-3358.
84. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-1737.
85. Strauss RS, Bradley LJ, Brolin RE. Gastric bypass surgery in adolescents with morbid obesity. J Pediatr 2001; 138:499-504.
86. Nadler EP, Youn HA, Ren CJ, Fielding GA. An update on 73 US obese pediatric patients treated with laparoscopic adjustable gastric banding: comorbidity resolution and compliance data. J Pediatr Surg 2008; 43:141-146. Largest reported series of bariatric surgery in adolescents to date.
87. Rand CS, Macgregor AM. Adolescents having obesity surgery: a 6-year follow-up. South Med J 1994; 87:1208-1213.
88. Lawson ML, Kirk S, Mitchell T, et al. One-year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents: a multicenter study from the Pediatric Bariatric Study Group. J Pediatr Surg 2006; 41:137-143; discussion -43.
89. Kalra M, Inge T, Garcia V, et al. Obstructive sleep apnea in extremely overweight adolescents undergoing bariatric surgery. Obes Res 2005; 13:1175-1179.
90. Ippisch HM, Inge TH, Daniels SR, et al. Reversibility of cardiac abnormalities in morbidly obese adolescents. J Am Coll Cardiol 2008; 51:1342-1348. This study demonstrates that bariatric surgery can reverse cardiac abnormalities in obese adolescents.
91. Loux TJ, Haricharan RN, Clements RH, et al. Health-related quality of life before and after bariatric surgery in adolescents. J Pediatr Surg 2008; 43:1275-1279.
92. Collins J, Mattar S, Qureshi F, et al. Initial outcomes of laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. Surg Obes Relat Dis 2007; 3:147-152.
93. Oliak D, Ballantyne GH, Weber P, et al. Laparoscopic Roux-en-Y gastric bypass: defining the learning curve. Surg Endosc 2003; 17:405-408.
94. Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142:621-632; discussion 32-35.
95. Cunneen SA, Phillips E, Fielding G, et al. Studies of Swedish adjustable gastric band and Lap-Band: systematic review and meta-analysis. Surg Obes Relat Dis 2008; 4:174-185.
96. Yitzhak A, Mizrahi S, Avinoach E. Laparoscopic gastric banding in adolescents. Obes Surg 2006; 16:1318-1322.
97. Holterman AX, Browne A, Dillard BE 3rd, et al. Short-term outcome in the first 10 morbidly obese adolescent patients in the FDA-approved trial for laparoscopic adjustable gastric banding. J Pediatr Gastroenterol Nutr 2007; 45:465-473.
98. Abbasi AA, Amin M, Smiertka JK, et al. Abnormalities of vitamin D and calcium metabolism after surgical treatment of morbid obesity: a study of 136 patients. Endocr Pract 2007; 13:131-136. Effects of bariatric surgery on calcium and vitamin D metabolism.
99. Johnson JM, Maher JW, DeMaria EJ, et al. The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 2006; 243:701-704; discussion 4-5.
100. Jin J, Robinson A, Hallowell P, et al. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature. Surgery 2007; 142:914-920.
101. Towbin A, Inge TH, Garcia VF, et al. Beriberi after gastric bypass surgery in adolescence. J Pediatr 2004; 145:263-267.
102. Rianthavorn P, Ettenger RB. Medication nonadherence in the adolescent renal transplant recipient: a clinician's viewpoint. Pediatr Transplant 2005; 9:398-407.
103. Apovian CM, Baker C, Ludwig DS, et al. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005; 13:274-282.
104. Papadia FS, Adami GF, Marinari GM, et al. Bariatric surgery in adolescents: a long-term follow-up study. Surg Obes Relat Dis 2007; 3:465-468.
105. Woodard CB. Pregnancy following bariatric surgery. J Perinat Neonatal Nurs 2004; 18:329-340.
106. Wittgrove AC, Jester L, Wittgrove P, Clark GW. Pregnancy following gastric bypass for morbid obesity. Obes Surg 1998; 8:461-464; discussion 5-6.
107. Dao T, Kuhn J, Ehmer D, et al. Pregnancy outcomes after gastric-bypass surgery. Am J Surg 2006; 192:762-766.
108. Roehrig HR, Xanthakos SA, Sweeney J, et al. Pregnancy after gastric bypass surgery in adolescents. Obes Surg 2007; 17:873-877.
109. Halm EA, Lee C, Chassin MR. Is volume related to outcome in healthcare? A systematic review and methodologic critique of the literature. Ann Intern Med 2002; 137:511-520.
110. Khuri SF, Henderson WG. The case against volume as a measure of quality of surgical care. World J Surg 2005; 29:1222-1229.
111. Nguyen NT, Paya M, Stevens CM, et al. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg 2004; 240:586-593; discussion 93-94.
112. Barlow S. Bariatric surgery in adolescents: for treatment failures or health-care system failures? Pediatrics 2004; 114:252-253.
113. DM Rodgers, Association APS. Bariatric surgery for adolescents: a view from the American Pediatric Surgical Association. Pediatrics 2004; 114:255-256.
114. Wittgrove AC, Buchwald H, Sugerman H, Pories W. Surgery for severely obese adolescents: further insight from the American Society for Bariatric Surgery. Pediatrics 2004; 114:253-254.